Biogen Inc. (BIIB) Stock Up After Upgrade at Citigroup Inc.

Biogen Inc. (NASDAQ: BIIB) shares rose in value on Tuesday February 7 on slower trade volume than normal after a number of analysts weighed in on the investing value of the stock with a upgraded rating.

U.S. stocks were up in early trade on Tuesday which could put the equity market on track to set new records.

Investors were focusing on earnings, with GM and Michael Kors making moves after reporting early.

S&P 500 futures ESH7, +0.31% rose 7 points, or 0.3%, to 2,293.50, while Dow Jones Industrial Average futures YMH7, +0.46% tacked on 70 points, or 0.4%, to 20,042. Nasdaq-100 futures NQH7, +0.48% added 14 points, or 0.3%, to 5,171.75.

Analysts at Citigroup Inc. upgraded shares of Biogen Inc. (NASDAQ: BIIB) from Neutral to Buy today. The company currently has a rating of Buy on the stock. As a means of comparison, a number of other analysts have issued reports on the stock recently, and Biogen Inc. has earned a consensus one-year price target of $319.98, above the opening price of $269.47, a difference of 11.96 percent. Biogen Inc. stock has a 52-week high of $333.65. Usually, after analysts give an upgrade report on a stock, they will subsequently issue sporadic updates, often followed by a price target change.

Shares of Biogen Inc. (NASDAQ: BIIB) opened at $269.47 yesterday and traded in a range between, $266.35 and $269.67, and last traded at $267.46, which is a jump of $2.55 from the previous closing price.

Biogen Inc. (NASDAQ: BIIB) now has a market cap of 57.76B.

Biogen Inc. (NASDAQ: BIIB) Average Daily Trading Volume

The stock’s average daily volume is 1,860,430 shares out of a total float 215,612,000 and some 293,890 shares traded hands yesterday, 43 percent lower than the average. lower than normal. Look for trading volume to pick up in the coming days as momentum traders often use swings in trading volume to identify heavy volume accumulation or distribution by institutional investors.

While increased trading for one day will not mean much, however, a trend of heavy trading volume on the buy side over a period of days or weeks sends a positive signal to market traders that institutions may be moving in, so institutional sponsorship is very important.

Institutional sponsorship is defined by ownership of a stock by mutual funds, banks, pension funds and other large institutions.

These professional investors have substantial teams of analysts that research thousands of stocks. So watching their interests is a good way to ensure you are buying the right stocks.

Biogen Inc. (NASDAQ: BIIB) Moving Averages

A moving average can also act as support or resistance. In an uptrend a 50-day, 100-day or 200-day moving average may act as a support level, as shown in the figure below.

This is because the average acts like a floor (support), so the price bounces up off of it.

In a downtrend a moving average may act as resistance; like a ceiling, the price hits it and then starts to drop again.

By spotting trends, moving averages allow traders to make those trends work in their favor and increase the number of winning trades.

With that in mind, Biogen Inc. (NASDAQ: BIIB) now has a 50-day MA of $282.92 and 200-day MA of $298.01. It has traded in a 52-week range between $223.02 – 333.65 and today’s last price is 19.84%% lower than the 52 week high of $333.65.

Indeed, earnings growth is among the most critical things to look at in regards to stock investing and, accordingly, investors identify companies that have been successful at growing their earnings by at least 25% over 3 consecutive years.

DISCLOSURE: The views and opinions expressed in this article do not represent the views of the website. Readers should not consider statements made by the author as formal recommendations and should consult their financial adviser before making any investment decisions. To read our full disclosure, please see our terms and conditions page.

Leave a Reply

Your email address will not be published. Required fields are marked *